News About: Pharm. Industry
Weakened profitability caused by high rate of cost to sales
It was criticized pharmaceutical companies’ profitability is getting weaker as the rate of cost to sales is increasing due to their increased sales of merchandise.
According to the Yakup Shinmoon’s(www.yakup.com) ana...
Series of rebate incidents change large hospitals’ purchase methods on drugs
Impacted by recent rebate incidents, large hospitals in Busan are changing their drug purchasing process.
When it comes to Busan Medical Center which one of its doctors were arrested for acceptance of hundred million...
Shire Korea establishes genetic disorder department
Shire Korea(CEO Hee-Seok Moon) announced to establish a genetic disorder department and start a genetic disorder treatment business in Korea on January 1 2017.
Shire Korea is expected to develop and supply innovative...
Hanmi apologies while prosecution arrests 4 employees taking unfair advantages from stockOn the 13th, the prosecution which has investigated the Hanmi Pharm’s ‘closed information use’ incident for about 2 months announced it exposed 45 people who took unfair advanta...
|
15 professional CEOs in listed pharmas will complete term in office next year
Professional managers in 5 companies, such as Jeil Pharmaceutical CEO Seok-Jae Sung and Ildong Holding CEO Yeon-Jin Jung, will complete their term in office on March next year.
According to the Yakup Shinmoon’s(www.y...
“Trump’s pharmaceutical policies have too many uncertain aspects and will not bring immediate impacts”
President-elect Donald Trump’s policies may bring positive impacts on Korean biosimilars’ entry to overseas markets, but an anticipation was made that it will not significantly influence the pharmaceutical market, yet...
What are Korean drug market’s plans on ‘unexpected Trump’?
While concerns get higher towards the election of Donald Trump who stressed importance of protectionism at the presidential election, the Korean pharmaceutical industry had a time to think about countermeasures agains...
Prosecution about to announce investigation report about 19 pharmas’s rebate case
While rebate incidents surprise the pharmaceutical industry at the end of the year, the rebate case involved with the hospital located in Jeonju, which will come to an end soon, has make pharmaceutical companies tense...
Names of drug, medicine and new drug cannot be used except for drug manufacturers
So far, it was restricted to launch drink products containing more than 30mg of caffeine for a take, but it will be relaxed so that pharmaceutical companies will be able to launch more various products.
Moreover, any...
Pharmas to watch on employees’ misbehavior according to president’s impeachment
‘Careful… and careful again’
A special command was ordered for pharmaceutical companies. A caution was made for their employees to be careful not only for company work, but on daily life. It is, however, no surprisin...
